Limited antibody uptake in brain for low-expressing targets at the BBB
Proteomic analysis reveal highly expressed proteins at the BBB
Brain uptake of antibodies against highly abundant BBB targets follows in vivo dosing
CD98hc is a robust and novel BBB target for antibody therapeutics for CNS diseases